This finding aligns with our research objectives, highlighting the anti-inflammatory and antioxidative pharmacological benefits of LG2 via the TNF-α pathway, potentially suppressing inflammatory cytokine secretion and reducing cellular damage during early PF development. This evidence concerns the gene TNF and pemphigus foliaceus.